Change in Management

July 20, 2026 The Manager The Manager Listing Department Listing Department BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers “Exchange Plaza” C – 1, Block G Dalal Street Bandra Kurla Complex, Bandra (East) Mumbai – 400 001 Mumbai – 400 051 Through: BSE Listing portal Through: NEAPS Scrip code: 500027 Symbol: ATUL Dear Sir | Madam, Subject: Changes in senior management Pursuant to Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“the Regulations”), we inform you about changes in senior management team. The details as required under the Regulations are as under: a) reason for Dr Prabhakar Chebiyyam, Mr Vinay Desai, Executive Vice change President, Pharmaceuticals, President, Technology and b) date of retired and Mr Dhaval Vashi, took Manufacturing become a member appointment | over charge as Senior Vice of senior management team cessation President, Pharmaceuticals. effective July 18, 2026. Accordingly, Dr Vashi became a member of senior management team effective July 18, 2026 in place of Dr Chebiyyam. c) brief profile (in Dr Dhaval Vashi is associated Mr Vinay Desai is associated with case of with the Company since the Company since December appointment) December 2022. He has about 22 2022. He has about 35 years of years of experience in Business experience in manufacturing and Development. He holds technology development. He postgraduate degree in science holds a graduate degree in (organic chemistry) and a chemical engineering. doctorate degree in synthetic organic chemistry. d) disclosure of Not applicable Not applicable relationships between directors We request you to inform the members of the exchange accordingly. Thank you, Yours faithfully For Atul Limited Lalit Patni Company Secretary and Chief Compliance Officer